11. |
Tegaserod relieves global symptoms of irritable bowel syndrome |
|
Inpharma Weekly,
Volume &NA;,
Issue 1350,
2002,
Page 13-14
Raewyn Poole,
Preview
|
|
摘要:
The selective serotonin-4 receptor antagonist tegaserod ['Zelmac', 'Zelnorm'] is effective in the treatment of constipation-predominant irritable bowel syndrome (IBS), according to a meta-analysis of four phase III studies presented at the annual Digestive Disease Week (DDW) meeting [San Francisco, US; May 2002]. Tegaserod was shown to provide a significant improvement in global IBS symptoms, compared with placebo, and was generally well tolerated. Importantly, there was no conclusive evidence that the incidence of abdominal surgery, including cholecystectomy, was increased in tegaserod, compared with placebo, recipients.
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
12. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1350,
2002,
Page 15-15
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
13. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1350,
2002,
Page 16-16
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
14. |
Endometrial safety of continuous combined HRT |
|
Inpharma Weekly,
Volume &NA;,
Issue 1350,
2002,
Page 17-17
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
15. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1350,
2002,
Page 18-18
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
16. |
PRODUCT INTRODUCTIONS |
|
Inpharma Weekly,
Volume &NA;,
Issue 1350,
2002,
Page 19-19
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|